Tech Company Financing Transactions

Pulmocide Funding Round

SR One Capital Management, F-Prime Capital and Johnson & Johnson Development Corporation participated in a $30 million Series B funding round for Pulmocide. The financing round was announced on 3/22/2017.

Transaction Overview

Company Name
Announced On
3/22/2017
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series B
Proceeds Purpose
The proceeds will enable Pulmocide to progress its wholly-owned assets through early clinical development.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
44 Southampton Buildings
London, WC2A 1AP
UK
Email Address
Overview
Pulmocide is a privately-held company located in London, developing novel small molecule inhaled medicines for the treatment of life threatening respiratory infections caused by RSV and Aspergillus.
Profile
Pulmocide LinkedIn Company Profile
Social Media
Pulmocide Company Twitter Account
Company News
Pulmocide News
Facebook
Pulmocide on Facebook
YouTube
Pulmocide on YouTube

Management Team

Title
Name
Email & Social
Chairman
Daniel Burgess
  Daniel Burgess LinkedIn Profile  Daniel Burgess Twitter Account  Daniel Burgess News  Daniel Burgess on Facebook
Chief Medical Officer
Lance Berman
  Lance Berman LinkedIn Profile  Lance Berman Twitter Account  Lance Berman News  Lance Berman on Facebook
Chief Scientific Officer
Pete Strong
  Pete Strong LinkedIn Profile  Pete Strong Twitter Account  Pete Strong News  Pete Strong on Facebook
VP - Bus. Development
Jennifer Cayer
  Jennifer Cayer LinkedIn Profile  Jennifer Cayer Twitter Account  Jennifer Cayer News  Jennifer Cayer on Facebook
VP - Operations
David Mantus
  David Mantus LinkedIn Profile  David Mantus Twitter Account  David Mantus News  David Mantus on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/22/2017: Shipt venture capital transaction
Next: 3/22/2017: RavenPack venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to document every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary